112 related articles for article (PubMed ID: 1289497)
1. Comparison of the effects of halothane and propranolol on the effective refractory period and the ventricular activation in a canine myocardial infarction model.
Hashimoto H; Imamura S; Ikeda K; Nakashima M
J Pharmacobiodyn; 1992 Nov; 15(11):623-30. PubMed ID: 1289497
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic effects of volatile anesthetics, sevoflurane and halothane, in a canine myocardial infarction model.
Hashimoto H; Imamura S; Ikeda K; Nakashima M
J Anesth; 1994 Mar; 8(1):93-100. PubMed ID: 28921208
[TBL] [Abstract][Full Text] [Related]
3. Effects of volatile anesthetics, enflurane, isoflurane, and halothane on ventricular delayed activation in a canine myocardial infarction model.
Imamura S; Hashimoto H; Ikeda K; Nakashima M
J Electrocardiol; 1994 Jan; 27(1):41-8. PubMed ID: 8120477
[TBL] [Abstract][Full Text] [Related]
4. Suppression of ventricular arrhythmias by volatile anesthetics in a canine model of chronic myocardial infarction.
Deutsch N; Hantler CB; Tait AR; Uprichard A; Schork MA; Knight PR
Anesthesiology; 1990 Jun; 72(6):1012-21. PubMed ID: 2350016
[TBL] [Abstract][Full Text] [Related]
5. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
Hashimoto H; Satoh N; Nakashima M
J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interaction between class I antiarrhythmic drugs and halothane in depressant effects on ventricular activation in a canine myocardial infarction model.
Hashimoto H; Imamura S; Ikeda K; Nakashima M
Biol Pharm Bull; 1994 Mar; 17(3):449-53. PubMed ID: 8019516
[TBL] [Abstract][Full Text] [Related]
7. Halothane anesthesia reduces inducibility of ventricular tachyarrhythmias in chronic canine myocardial infarction.
Denniss AR; Richards DA; Taylor AT; Uther JB
Basic Res Cardiol; 1989; 84(1):5-12. PubMed ID: 2923606
[TBL] [Abstract][Full Text] [Related]
8. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
Kondoh K; Hashimoto H; Nishiyama H; Umemura K; Ozaki T; Uematsu T; Nakashima M
J Cardiovasc Pharmacol; 1994 Apr; 23(4):674-80. PubMed ID: 7516022
[TBL] [Abstract][Full Text] [Related]
9. Effects of astemizole on ventricular activation, effective refractory periods, RT intervals, and programmed stimulation-induced ventricular arrhythmias in dog hearts with myocardial infarction.
Hashimoto H; Nishimoto M; Ohmura T; Watanabe S; Ikeda Y; Nakamura R; Umemura K; Nakashima M
J Cardiovasc Pharmacol; 1998 Feb; 31(2):286-91. PubMed ID: 9475271
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological and antiarrhythmic effects of propranolol in canine acute myocardial ischemia.
Kupersmith J; Shiang H; Litwak RS; Herman MV
Circ Res; 1976 Apr; 38(4):302-7. PubMed ID: 1260972
[TBL] [Abstract][Full Text] [Related]
11. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.
Ozaki T; Uematsu T; Nagashima S; Nishimoto M; Nakashima M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):478-87. PubMed ID: 1766473
[TBL] [Abstract][Full Text] [Related]
12. Effects of astemizole on ventricular activation delay and RT intervals in a canine myocardial infarction model.
Nishimoto M; Hashimoto H; Ohmura T; Ikeda Y; Watanabe S; Ohashi K; Umemura K; Nakashima M
Biol Pharm Bull; 1997 Sep; 20(9):1020-3. PubMed ID: 9331990
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic effects of flecainide against canine ventricular arrhythmias induced by two-stage coronary ligation and halothane-epinephrine.
Dobmeyer D; Muir WW; Schaal SF
J Cardiovasc Pharmacol; 1985; 7(2):238-44. PubMed ID: 2581074
[TBL] [Abstract][Full Text] [Related]
14. Comparative electrophysiological effects of the antidepressants fluvoxamine and amitriptyline in the canine heart after myocardial infarction.
Ikeda Y; Nishimoto M; Shimazu Y; Hashimoto H; Umemura K; Nakashima M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):30-7. PubMed ID: 8832585
[TBL] [Abstract][Full Text] [Related]
15. In vivo electrophysiological effects of lidocaine in canine acute myocardial infarction.
Kupersmith J; Antman EM; Hoffman BF
Circ Res; 1975 Jan; 36(1):84-91. PubMed ID: 1116233
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the electropharmacological effects of verapamil and propranolol in the halothane-anesthetized in vivo canine model under monophasic action potential monitoring.
Shiina H; Sugiyama A; Takahara A; Satoh Y; Hashimoto K
Jpn Circ J; 2000 Oct; 64(10):777-82. PubMed ID: 11059619
[TBL] [Abstract][Full Text] [Related]
17. Cardiac conduction interactions of propranolol and verapamil with halothane in pentobarbitone-anaesthetized dogs.
Hart AP; Royster RL; Johnston WE
Br J Anaesth; 1988 Dec; 61(6):748-53. PubMed ID: 3207546
[TBL] [Abstract][Full Text] [Related]
18. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy.
Avitall B; Hare J; Zander G; Bockoff C; Tchou P; Jazayeri M; Akhtar M
Circulation; 1992 Apr; 85(4):1582-93. PubMed ID: 1555296
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the cardiovascular effects of acupuncture (moxibustion) by propranolol in dogs during halothane anaesthesia.
Lee DC; Lee MO; Clifford DH; Morris LE
Can Anaesth Soc J; 1976 May; 23(3):307-18. PubMed ID: 938968
[TBL] [Abstract][Full Text] [Related]
20. The effects of halothane on ventricular tachycardia in intact dogs.
Gallagher JD; McClernan CA
Anesthesiology; 1991 Nov; 75(5):866-75. PubMed ID: 1719848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
